Cutler Group LP Uro Gen Pharma Ltd. Transaction History

Cutler Group LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 18, 2023	BUY	$8.75 - $14.29 $3,500 - $5,716	400 New	400 $4,000
Q3 2022 Oct 25, 2022	BUY	$7.21 - $9.41 $3,605 - $4,705	500 New	500 $4,000
Q4 2020 Jan 21, 2021	SELL	$17.54 - $25.43 $61,390 - $89,005	-3,500 Closed	0 $0
Q3 2020 Oct 27, 2020	SELL	$18.81 - $26.42 $46,517 - $65,336	-2,473 Reduced 41.4%	3,500 $67,000
Q2 2020 Jul 22, 2020	BUY	$16.5 - $29.7 $98,554 - $177,398	5,973 New	5,973 $156,000

113

24M

46.9K

44.3K

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $373M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.